Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Verrica Pharmaceuticals

Verrica Pharmaceuticals
2013 FOUNDED
PUBLIC STATUS
11-20 EMPLOYEES
VRCA STOCK SYMBOL
$8.80 SHARE PRICE (As of Friday Closing)
Description

Verrica Pharmaceuticals Inc a clinical-stage biopharmaceutical company. The company is primarily focused on identifying, developing and commercializing pharmaceutical products for the treatment of skin diseases with unmet needs. Its pipeline product includes NCT03377803, and NCT03377790.

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • Durham, NC
  • United States

+1 (610) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Verrica Pharmaceuticals’s full profile, request a free trial.

Verrica Pharmaceuticals Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$6.44 - $23.29 $226M $9.12 -$1.72 55.6K 25.7M

Verrica Pharmaceuticals Financials Summary

In Thousands,
USD
TTM
31-Mar-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 188,086 203,551
Revenue 0 0 0 0
EBITDA (27,959) (21,859) (4,457) (1,913)
Net Income (26,253) (20,648) (4,459) (1,913)
Total Assets 85,979 91,906 9,083 544
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Verrica Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Verrica Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Verrica Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is reserved for PitchBook Platform users. To explore Verrica Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook
To view this company’s complete Cap Table, request access »

Verrica Pharmaceuticals Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aclaris Therapeutics Formerly VC-backed Malvern, PA 000 00000 00000000000 00000
00000000 000000000 Venture Capital-Backed San Diego, CA 0000000000
0000 0000000000000 Formerly PE-Backed West Chester, PA 000000&0
0000000 0000000000 Venture Capital-Backed Langhorne, PA 000 00000 00000000000 00000
00000 000000000000 Formerly PE-Backed Fort Myers, FL 00 000000000000
To view this company’s complete list of competitors, request access »

Verrica Pharmaceuticals Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Verrica Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Verrica Pharmaceuticals Executive Team (6)

Name Title Board
Seat
Contact
Info
Ted White Chief Executive Officer & President
Jayson Rieger Ph.D Chief Operating Officer & Board Member
Matthew Davidson Ph.D Founder, Chief Scientific Officer & Board Member

3 Former Executives

You’re viewing 3 of 6 executives. Get the full list »

Verrica Pharmaceuticals Board Members (5)

Name Representing Role Since Contact
Info
Glenn Oclassen Verrica Pharmaceuticals Board Member & Advisor 000 0000
Jayson Rieger Ph.D Verrica Pharmaceuticals Chief Operating Officer & Board Member 000 0000
Matthew Davidson Ph.D Verrica Pharmaceuticals Founder, Chief Scientific Officer & Board Member 000 0000
Paul Manning PBM Capital Group Board Member 000 0000
Sean Stalfort Verrica Pharmaceuticals Board Member 000 0000